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Introduction
Clostridioides difficile (C. difficile) is a Gram-positive 
bacillus, spore-forming and toxin producer that in recent 
years has represented a great challenge in terms of 
infection control within health institutions in the world, 
being one of the main etiological agents of the health care-
associated infections (HCAI)  [1]. C. difficile infection 
(CDI) is the most common cause of diarrhea associated 
with health care and long-term use of antimicrobials [1]. 
The transmission of this pathogen mainly occurs in 
hospital facilities, where exposure to antimicrobials and 
contamination of the environment by C. difficile spores 
is common  [1]. C. difficile produces toxins that cause 
damage to the epithelial cells, these toxins are known as 
toxin A and toxin B [1]. Toxin A, called enterotoxin, which 
is more potent, increases secretion, causes more mucosal 
damage and inflammation, however, in cell cultures, toxin 
B has been shown to have greater cytotoxic activity, and 
in subsequent studies it has been shown that it is more 
toxic in the human colonic epithelium than toxin A [1, 2]. 
Worldwide, it is estimated that between 20 and 30% of 
cases of diarrhea associated with antibiotics are caused 
by C. difficile. In Canada, a rate between 3.8 to 9.5 cases 
per 10,000 patient days is calculated between 1997 and 
2005. As of 2002, more severe and recurrent outbreaks 
have been observed, the great majority associated with the 
use of antimicrobials, mainly fluoroquinolones, with an 
attributable mortality of 6.9 to 7.5% [3, 4].
In some hospitals in Mexico, the presence of C. difficile has 
been detected as one of the main infectious agents, showing 
a higher prevalence in hospital services such as Internal 
Medicine, General Surgery, and Intensive Care Units [5]. 
According to the literature, the main risk factor for C. difficile 
infection is the indiscriminate use of antimicrobials, mainly 
from the family of carbapenems and cephalosporins [6, 7]. 
The outbreaks that have occurred in our country have shown 
difficulties in their control and prevention, even remaining 
constant with an endemic behavior [8, 9].
The aim of this work was to describe the hospital 
outbreak of C. difficile infection and the impact of the 
prevention and control measures that were implemented 
in the “Hospital Juárez de México” (HJM).
Methods
Study design
A cross-sectional, descriptive, observational, and 
retrospective study was designed. All information 
was obtained from the hospital outbreak and from the 
Introduction. To describe the outbreak of Clostridioides diffi-
cile infection (CDI), and the impact of the prevention and con-
trol measures that were implemented in the “Hospital Juárez de 
México” (HJM) for its control.
Methods. A cross-sectional, descriptive, observational, and ret-
rospective study was designed. All information on the hospital 
outbreak and on health care-associated infections (HCAI) was 
obtained from the files of the Hospital Epidemiological Surveil-
lance Unit (HESU) of the HJM. 
Results. A total of 15 cases of CDI were detected from February 
20th to May 22nd, 2018, which represented 55.6% and 44.4% for 
the male and female gender, respectively, with an average age of 
56 years and a range of 24 to 86 years old. It was possible to iden-
tify six failures and deficiencies that involved health personnel 
and hospital logistics through analyses based on the situational 
diagnosis in the services involved and through the construction 
of cause-effect diagrams. Additionally, through the detection of 
the outbreak by means of laboratory tests and timeline, the HESU 
team implemented measures and prospective surveillance to con-
trol and prevent the emergence of new cases.
Conclusions. The implementation of basic quality tools, control 
measures, and the prospective epidemiological surveillance had a 
positive impact on the control against the outbreak of C. difficile 
producing toxin B.
ReseaRch papeR
Implementation of control measures  
against an outbreak due to Clostridioides difficile  
producing toxin B in a tertiary hospital in Mexico
OSCAR SOSA-HERNÁNDEZ1, BERNARDINA MATÍAS-TÉLLEZ1, JUANA GONZÁLEZ-MARTÍNEZ1,  
ROCIO JUÁREZ-VARGAS1, NORMA ELIZABETH GONZÁLEZ-GONZÁLEZ1, ABRIL ESTRADA-HERNÁNDEZ1, 
MONSERRAT RUÍZ-SANTANA2, JUAN CARLOS BRAVATA-ALCÁNTARA2, JUAN MANUEL BELLO-LÓPEZ3
1 Unidad de Vigilancia Epidemiológica Hospitalaria, Hospital Juárez de México; 2 Laboratorio de Genética y Diagnóstico Molecular, 
Hospital Juárez de México; 3 División de Investigación, Hospital Juárez de México
Keywords
Hospital outbreak • Infection control • Clostridioides difficile • Toxin B
Summary
CONTROL OF A OUTBREAK DUE TO CLOSTRIDIOIDES DIFFICILE
E509
health care-associated infections (HCAI) from the 
Hospital Epidemiological Surveillance Unit (HESU) 
of the HJM.
Period of analysis and case definition of CDI
The period of the outbreak study was from February 
20th to May 22nd, 2018. For the identification of cases, 
operational definitions were made and inclusion criteria 
was included such as patient of any age who had 
been hospitalized for at least 48 hours and who had 
presented more than three diarrheic stools in 12 hours, 
accompanied by one or more of the following symptoms: 
fever, abdominal distension and/or abdominal pain was 
considered as a suspected case of CDI. For a confirmed 
case of CDI, we had to meet the operational definition 
of a suspected case and have a positive result on any of 
the following tests:
• commercial immunochromatographic qualitative test 
against glutamate dehydrogenase (GDH) (CERTEST 
Clostridium difficile antigen GDH, Certest Biotec 
S.L.);
• real-time PCR amplification of a fragment of the 
gene coding for C. difficile toxin B was performed by 
using the automated BD MAX technology (Becton 
Dickinson) according to the supplier’s instructions.
Collection and analysis data 
The outbreak information was handled in Microsoft 
Excel package (Microsoft Corporation; Redmond, WA). 
The variables and risk factors described and analyzed 
were age, gender, hospital service, use of antimicrobials 
before CDI diagnosis, use of proton pump inhibitors, 
and type of diagnosis. Frequencies and percentages are 
used for data description. 
Results
A total of 15 cases of CDI were detected during February 
20th to May 22nd, 2018. The index case was a patient who 
had a history of having been previously hospitalized in 
the HJM during December 2017 and January 2018 in 
General Surgery. One week after his hospital discharge, 
his start with characteristic symptomatology in his home 
(diarrheic discharge, abdominal pain and fever). Since 
the clinical picture began at home, the health personnel 
who valued his readmission did not suspect that the 
etiologic agent was C. difficile. For this reason, there 
was a delay in the diagnosis and in the implementation 
of preventive measures, which generated exposure to 
patients and health personnel.
The epidemiological investigation and case analysis 
showed that 66.6 and 34.4% of patients corresponded 
to the male and female gender, respectively, with an 
average age of 56 years and a range of 24 to 86 years of 
age. According to the hospital services, where the cases 
were detected, 40% were in Internal Medicine, 26.7% 
in General Surgery, 13.3% in Neurosurgery, 13.3% in 
Hematology, and 6.7% in Thoracic Surgery. According 
to the timeline, 13.3% was detected in February 40% 
in March, and 46.7% in April. Figure  1 shows the 
distribution of cases in the epidemic curve. 
Three deaths were recorded, of which only one was 
related to CDI, therefore, the fatality rate was 5.6%. 
The index case began with diarrheic discharge in 
February; however, when reviewing the epidemiological 
background, he was hospitalized at the HJM in 
December; despite identifying this data, it could not 
be determined whether if it was the primary case or the 
source of the outbreak. Among the risk factors detected, 
88.9% of the cases had some antimicrobial scheme, the 
most commonly used being carbapenems, quinolones, 
Fig. 1. Epidemic curve of outbreak due to Clostridioides difficile infection.
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and cephalosporins. In all cases, the use of proton pump 
inhibitors was detected. When determining that it was 
a hospital outbreak due to C. difficile, the HESU team 
began with the prospective epidemiological surveillance, 
the implementation of control measures for the outbreak, 
and the prevention of the appearance of new cases, based 
on the situational diagnosis carried out in the services 
involved, where faults and deficiencies were identified 
and outlined in the cause-effect diagram (Fig. 2).
Implementation of outbreak control 
measures
Hygiene and hand washing, and contact precautions
During the outbreak, a low percentage of adherence to 
hygiene and hand washing was detected in the services 
involved, the above was determinate by personalized 
questioning. Therefore, training for the personnel of the 
involved areas on the correct technique of hygiene and 
hand washing, as well as, the five moments for hand 
hygiene was carried out. A total of 118 health workers from 
the hospital wards involved were trained, of which 75% 
were nurses, 13% cleaning staff, 9.2% doctors, and 2.7% 
were support staff. 0.1% corresponded to administrative 
staff, family members, and patients. These measures were 
applied to patients who met the operational definition of 
a suspected case of CDI. In addition, family members, 
patients, and health personnel were trained in the matter 
of the correct use of personal protective equipment.
Hospital cleaning and disinfection 
A diagnosis of the situation was performed, where it 
was identified that the hospital cleaning and disinfection 
process was not standardized, and it had errors in the 
sequence of steps. Consequently, it was decided to use 
two concentrations of sodium hypochlorite, 1,600 ppm 
for routine cleaning, and 5,000 ppm for final cleaning at 
patient discharge.
The cleaning of the biomedical equipment and objects 
that were found inside the patient’s room or environment, 
was carried out daily and at the time of the patient’s 
discharge with towels impregnated with peroxide. 
This step was complementary to disinfection with the 
chlorine concentrations mentioned above, before and 
after, but always together. As a last step in the sequence 
of disinfection, in the suspected or confirmed cases, the 
nebulization with hydrogen peroxide with silver particles 
was used, where it was requested by the services and 
authorized by the staff of the HESU, and after this step a 
patient could be allowed to enter the room. 
Laboratory diagnosis
When a suspect case was detected, the sample of diarrheic 
stools was collected and submitted for emergency diagnosis 
to the Genetics and Molecular Diagnostic Laboratory of the 
HJM for their corresponding study. One of the weaknesses 
detected during the study process of the outbreak was 
that the medical and nursing staff did not have sufficient 
knowledge to perform a differential diagnosis of CDI. 
Therefore, the necessary training was initiated to identify 
CDI and the operational definition of the case. The second 
problem was that even when the personnel that identified a 
suspected case of CDI, they did not notify it, the case was 
detected through active epidemiological surveillance. The 
third and final problem was that samples were occasionally 
sent to the laboratory for CDI diagnosis.
Fig. 2. Ishikawa diagram of outbreak due to Clostridioides difficile infection.
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Cohort isolation
One of the obstacles for the isolation of CDI cases was 
the structural characteristic of the HJM, since it limited 
the correct application of precautions contact measures, 
thus, relocation of beds and/or rooms was carried out 
in order to be able to shape specific and unique areas 
for suspected and confirmed cases. These measures were 
carried out until the discharge of the patient. In the same 
period of the outbreak, a total of three positive cases of C. 
difficile coming from other hospital units were identified, 
along with eight cases of gastroenteritis associated with 
health care with negative results to C. difficile.
Intervention with health workers
During training on hygiene and hand washing, the matter 
of identification, notification, diagnosis and treatment of 
suspected or confirmed cases of CDI was also addressed. 
The training covered the following points:
• operational definition of suspected case of CDI to 
improve detection;
• sample submission to the central or research 
laboratory for the timely diagnosis of CDI cases;
• application and registration in clinical file and medical 
indications of contact precautions in suspected and 
confirmed cases of CDI;
• effective communication of the suspicion or 
confirmation of the CDI to the interconsultant, 
surgical, and auxiliary diagnostic services (imaging);
• correct cleaning and disinfection of biomedical 
equipment in contact with suspected or confirmed 
CDI patients;
• interconsultation to the infectology service when 
detecting a suspected case of CDI for the timely 
initiation of antimicrobial treatment.
Discussion
To our knowledge, this is the first study of a hospital 
outbreak of diarrhea caused by C. difficile producing 
toxin B in Mexico, although there are previous reports in 
our country of the presence of this toxin, they only focus 
on isolates of clinical origin [10].
It is known that the identification of the source of 
dissemination in a C. difficile outbreak is very complex, 
which is why it is necessary to take into account that 
the hospital environment is probably the main source 
of contamination. This is due to poor cleaning and 
disinfection processes, combined with a low adherence 
to hygiene and hand washing of health workers [10]. The 
constant training and supervision of health personnel 
on hygiene and hand washing, and on cleaning and 
disinfection is a task of great importance, since it is 
easy to lose habits in the application of these measures. 
Previous studies have shown that hygiene and hand 
washing are the most important measures for the 
prevention and control of HCAI [11, 12].
One of the points to improve, is the importance of 
having an effective cleaning and disinfection process, 
with the appropriate products, of the areas involved in 
the circulation of C. difficile. Hospital environments 
should be evaluated, since there are different surfaces 
and biomedical equipment that can be difficult 
to disinfect, such as mattress surfaces, beds, and 
toilets [13]. The disinfectants that are used should be 
evaluated, as well as the concentrations to achieve a 
significant reduction of the spores [11]. Wong et al., 
2018, concluded that the use of disinfectants with 
sporicidal activity in the hospital environment after 
discharge of the patient with CDI helps to reduce 
the risk of cross-transmission of C. difficile  [14]. 
The effectiveness of cleaning and disinfecting 
with impregnated towels or with nebulization with 
hydrogen peroxide, complemented with silver 
particles has been demonstrated [15-17].
To obtain positive results with this type of products, 
it must be considered that they will always have to be 
complementary to the use of suitable concentrations of 
chlorine, either before or after the cleaning and disinfection 
step [18, 19]. They must be used strategically to optimize 
this input, and always with good communication with the 
technical team in charge of the application and with the 
hospital services involved [20, 21].
Although C. difficile is an infectious agent that is difficult 
to control, and that in a large number of hospitals its 
presence has an endemic behavior, efforts to make 
effective prevention and control measures of the outbreak 
must be constant with the trainings and supervisions in 
the hospital services involved. It is important to mention 
that hospital epidemiological surveillance actions work in 
a similar way to field epidemiology, having the structure 
based on the surveillance of morbidity, mortality, and 
by laboratory. It is necessary to establish the operational 
definition of CDI cases, both of suspected and confirmed 
cases, the technique in collecting and submitting 
samples for laboratory diagnosis, and the assessment 
by endoscopy and pathology services, if required. The 
establishment of these parameters will allow to carry 
out a proper epidemiological surveillance of cases of 
CDI. Furthermore, it is important to integrate indicators 
such as the incidence rate  [22, 23]. One factor to take 
into account of the CDI cases is the increase in the costs 
derived from medical care, van Buerden et al, 2017, 
calculated the costs attributable to the care and control 
of an outbreak of C. difficile ribotype 027, and it was of 
approximately € 1,222,376, the factor that increased the 
cost was the increase in hospital stay and the closing 
of rooms to implement contact precautions  [24]. The 
impact on the economy of the institutions is important, 
without considering the cost that it generates to the 
family members of the infected patients. One of the 
characteristics of the HJM, which represents a barrier for 
infection control, is the deficient number of rooms for the 
isolation of cases, these limits and impacts the adherence 
to precautions based on the transmission of diseases, in 
this case contact precautions. Ideally when making plans 
on the construction of new hospitals or the remodeling of 
existing institutions, the team of the HESU should consider 
aspects related to the prevention and control of infections. 
Without a doubt, the effective communication with the 
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staff of the diagnostic laboratories was the key to contain 
the outbreak, since there is a coordinated notification with 
the HESU team, which strengthens the timely detection 
activities. It is important to permanently assemble a system 
for the notification and detection of suspected cases of 
CDI to identify a case in a timely manner, initiate contact 
precautions and antimicrobial treatment, and effective 
measures of cleaning and disinfection. The importance 
of communicating this report is to raise awareness about 
the importance of prevention and control measures, which 
must be well executed and supervised, since the success or 
failure of the risk of infection to patients, family members, 
and health workers depends on this.
Conclusions
The implementation of effective and adequate 
measures of prevention and control of C. difficile 
are a constant challenge for hospital epidemiology, 
for which strategies should be designed for hospital 
structures, so that the results are as favorable as 
possible. The use of basic quality tools to carry out 
the analysis with a risk approach for the study of 
outbreaks is a methodology that we must explore, 
since they can give a wider perspective to face the 
barriers that are detected. Additionally, we must not 
forget that epidemiological surveillance is based on 
morbidity, mortality, and the laboratory, the latter was 
a strength for our HESU group, because having results 
in a timely manner allowed us to implement prevention 
and control measures in a short time.
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